Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

A Tiny Upstart Takes Aim at Robotic Surgery


A Tiny Upstart Takes Aim at Robotic Surgery

Intuitive Surgical's (NASDAQ: ISRG) robots enjoy a near monopoly in hospitals, but that could change following last week's FDA approval of TransEnterix's (NYSEMKT: TRX)  Senhance. Senhance is a robotic system that assists surgeons performing laparoscopic surgeries. It offers advantages, including haptic feedback, that could differentiate it from Intuitive Surgical's da Vinci system. Will TransEnterix carve out a meaningful slice of this fast-growing market?

Intuitive Surgical's ground-breaking da Vinci systems are reshaping laparoscopic surgery.

IMAGE SOURCE: TRANSENTERIX.

Continue reading


Source: Fool.com

Intuitive Surgical Inc Stock

€445.35
1.350%
There is an upward development for Intuitive Surgical Inc compared to yesterday, with an increase of €5.95 (1.350%).
With 36 Buy predictions and not a single Sell prediction Intuitive Surgical Inc is an absolute favorite of our community.
With a current price of 445.35 € Intuitive Surgical Inc is right around the predicted target price of 449 €.
Like: 0
Share

Comments